The effectiveness of melatonin in coronary heart disease-Reference-Cited by-同舟云学术

The effectiveness of melatonin in coronary heart disease

Published:2022-09-15 Issue:6 Volume:100 Page:285-287
ISSN:2412-1339
Container-title:Clinical Medicine (Russian Journal)
language:
Short-container-title:jour

Author:

Zaslavskaya R. M.¹

Affiliation:

1. Russian Academy of Science

Abstract

The article is dedicated to a review of the literature on the use of melatonin in patients with coronary artery disease, taking into account its participation in the regulation of the cardiovascular system, the function in the presence of a circadian rhythm of hemodynamic parameters and melatonin receptors in the muscular layer and endothelial tissue. The eff ect of melatonin on the organs of the cardiovascular system is due to its pronounced antioxidant activity, and the ability to infl uence vascular tone, heart rate, and inhibit platelet aggregation.

Publisher

Medical Informational Agency Publishers

Subject

General Medicine

Reference31 articles.

1. Malinovskaya N. K. Melatonin i serdechno-sosudistaya sistema / N. K. Malinovskaya [i dr.] // Melatonin v norme i patologii. – M., 2004. – S. 85–101. [Malinovskaya N. K. et al. Melatonin and cardiovascular system. Melatonin in norm and pathology. 2004: 85–101. (In Russian)].

2. Grossman E. et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am. J. M. 2006; 119 (10): 898–902.

3. Cuzzocrea S. et al. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur. J. Pharmacol. 2001; 426 (1–2): 1–10.

4. Salie R. et al. Protects Against ischemic reperfusion myocardial damage. J. Mol. Cell. Cardiol. 2001; 33 (2): 343–357.

5. Zaslavskaya R. M. et al. Melatonin, refractory hypertension, myocar dial ischemia and other challenges in nightly blood pressure lowering. Biomed. Pharmac. 2004; 58 (1): 129–134.